Previous 10 | Next 10 |
Two of the Largest U.S. Convenience Store Distributors Will Support VLN® Rollout into New States and Regions Expects Multiple Retail Chain Customers of Core-Mark and Eby-Brown to Carry 22nd Century's VLN® Cigarettes Buffalo, New York--(Newsfile Corp. - January 18, 2023) - 22nd Cen...
Proposed Menthol Ban Could Leave 22nd Century's VLN® Menthol King as the Only Menthol Cigarette in the $26 Billion U.S. Menthol Market FDA to Advance Reduced Nicotine Content Standards for All Combustible Cigarettes in Q4 2023 Paradigm Shift in Tobacco Health Policy and Regulation Exp...
NEW YORK, NY / ACCESSWIRE / December 16, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with 22nd Century Group. Toni had the pleasure of recently conducti...
Customer shipments continue uninterrupted, expects to resume production within weeks Buffalo, New York--(Newsfile Corp. - December 8, 2022) - GVB Biopharma , a 22nd Century Group company (NASDAQ: XXII), today provided updates on its operational recovery progress and customer shipments following...
The marijuana industry composite, the AdvisorShares Pure U.S. Cannabis ETF , is down by more than 50% this year so far. Cannabis stock investors are on the lookout for better times, not to mention the next big stock to invest in. Given that marijuana legalization is far from guaranteed in...
Established backup plans implemented to ensure continuous customer delivery Buffalo, New York--(Newsfile Corp. - November 21, 2022) - GVB Biopharma , a 22nd Century Group company (NASDAQ: XXII), today announced that a fire occurred at its GVB Biopharma distillate and isolate manufacturing fa...
BUFFALO, N.Y., Nov. 16, 2022 (GLOBE NEWSWIRE) -- GVB Biopharma , a 22nd Century Group company (Nasdaq: XXII ), today announced that it has opened a new, strategically-located distribution facility in the Netherlands to support its growing business in Europe, the Middle East,...
Summary A loss of over 59% in share price over the last year and dreadful profitability sum up 22nd Century Group's abysmal performance. The VLN and the GVB acquisition should turn the company profitable following the vast markets for both the VLN and the hemp. Since both init...
BUFFALO, N.Y., Nov. 15, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that the Company&...
BUFFALO, N.Y., Nov. 14, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that the Company ...
News, Short Squeeze, Breakout and More Instantly...
22nd Century Group Inc Company Name:
XXII Stock Symbol:
NYSE Market:
22nd Century Group Inc Website:
Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announce...
Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine cont...
Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissor...